Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5

Exclusion Criteria

• •1. Cardiogenic shock
• •2. Acute ST-elevation myocardial infarction within 48 hours from symptom onset.
• •3. Target lesion located in left main trunk or bypass graft.
• •4. Additional coronary intervention planned within 30 days of the procedure.
• •5. Non-successful treatment of other lesion(s) during the same procedure
• •6. Severe renal insufficiency (glomerular filtration rate ≤ 30 ml/min)
• •7. Contraindications to any components of the investigational devices or dual antiplatelet therapy
• •8. Pregnancy (present, suspected or planned) or positive pregnancy test.
• •9. Previous enrollment in this trial or participation in any other study at the time of enrollment.
• •10. Malignancies or other comorbid conditions with life expectancy less than 12 months or that may result in protocol non-compliance.
• •11. Patient's inability to fully comply with the study protocol